How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of bioresorbable stent implantation to treat coronary artery disease

    Closed for comments This consultation ended on at   Request commenting lead permission

    Description of the procedure

    Indications and current treatment

    Stenosis of the coronary arteries is usually caused by deposition of atherosclerotic plaque. This reduces blood flow to the heart muscle and is usually progressive. Symptoms of CAD typically include angina (chest pain that is exacerbated by exertion). A critical reduction of the blood supply to the heart may result in MI or death.

    The symptoms from a stenosed artery may be treated medically. This includes modifying risk factors (for example, smoking, hyperlipidaemia, obesity, hyperglycaemia) and treatment with medicines (for example, beta blockers, nitrates, calcium-channel blockers, antiplatelet agents, statins).

    If medical management fails or is inappropriate, the usual options are coronary artery bypass grafting, or percutaneous transluminal coronary angioplasty followed by stent insertion to maintain the patency of coronary artery.

    What the procedure involves

    BRSs are designed to be absorbed by the body over time. One aim is to reduce the risk of late complications such as thrombosis, which may occur after the use of metal stents. The other is to reduce the need for long-term anti-platelet medicines, with their risk of bleeding complications.

    The procedure is done under local anaesthesia. A guidewire is passed into the target coronary artery, usually from the radial or femoral artery under fluoroscopic image guidance. A balloon angioplasty catheter passed over the guidewire is used to dilate the coronary artery stenosis. A bioresorbable stent mounted on a balloon catheter is passed over the guide wire into the relevant segment of the artery. Then, it is expanded by inflation of the balloon within it. The balloon is then deflated and removed with the guide wire. The stent acts as a scaffold to hold the vessel open. Additional imaging, such as IVUS and OCT, is sometimes used to guide the procedure. This is to optimise positioning and deployment of the stent in the target coronary artery.

    BRSs are absorbed over time. Most BRSs are also drug-eluting, with a view to reducing the risk of restenosis. Antiplatelet medicines such as aspirin and clopidogrel are usually prescribed for at least 6 months after the procedure.